Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

DSPE-PEG(2000)-NHS ester is a PEGylated derivative of 1,2-distearoyl-sn-glycero-3-PE (DSPE; Item No. 15095).1 It has been used in the generation of micelles and in combination with other lipids in the formation of liposomes. DSPE-PEG(2000)-NHS ester-containing liposomes localize to the liver and tumor after intravenous administration in mice. Liposomes containing DSPE-PEG(2000)-NHS ester conjugated to the breast cancer targeting H6 peptide and encapsulating the DNA topoisomerase inhibitor doxorubicin (Item No. 15007) reduce tumor growth in an SK-BR-3 breast cancer mouse xenograft model.
WARNING This product is not for human or veterinary use.
1. Micromixer based preparation of functionalized liposomes and targeting drug delivery. ACS Med. Chem. Lett. 7(4), 429-434 (2016).